79247-86-2

Basic information

• Product Name: 4-TRIFLUOROMETHYLTHIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: 2-Thiazolecarboxylic acid, 4-(trifluoromethyl)-, ethyl ester;Ethyl 4-(trifluoromethyl)thiazole-2-carboxylate;Ethyl 4-(trifluoromethyl);thiazole-2-carboxylate;4-TRIFLUOROMETHYLTHIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER
• CAS NO: 79247-86-2
• Molecular Formula: C₇H₆F₃NO₂S
• Molecular Weight: 225.1882496
• Mol File: 79247-86-2.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 239.3±50.0 °C(Predicted)
• Appearance: /
• Density: 1.407±0.06 g/cm3(Predicted)
• PKA: -2.62±0.10(Predicted)
• CAS DataBase Reference: 4-TRIFLUOROMETHYLTHIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-TRIFLUOROMETHYLTHIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER(79247-86-2)
• EPA Substance Registry System: 4-TRIFLUOROMETHYLTHIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER(79247-86-2)

Safety Data

• Hazardous Substances Data: 79247-86-2(Hazardous Substances Data)

Usage

Uses

Ethyl 4-(Trifluoromethyl)thiazole-2-carboxylate is used as a reactant in the preparation of 2-acylaminothiazole derivatives as muscarinic M3 receptor positive allosteric modulators.

Upstream product

• 421-50-1 1,1,1-trifluoro-2-propanone 
• 16982-21-1 ethyl 2-amino-2-thioxoacetate 
• 51216-90-1 ethyl 2-thiooxamate 
• 431-35-6 3-bromo-1,1,1-trifluoroacetone 
• 64-17-5 ethanol 

Downstream Products

• 79247-85-1 4-Trifluoromethyl-thiazole-2-carboxylic acid methyl ester 
• 1251166-18-3 4-chloro-6-(4-methoxybenzyloxy)-2-(4-trifluoromethylthiazol-2-yl)pyrimidine 
• 1251166-88-7 4-(4-methoxybenzyloxy)-6-phenoxy-2-(4-trifluoromethylthiazol-2-yl)pyrimidine 
• 1251166-89-8 5-phenoxy-2-(4-trifluoromethylthiazol-2-yl)pyrimidin-4-ol 
• 1251166-25-2 6-(4,5-dimethylthiazol-2-yl)-4-(4-methoxybenzyloxy)-2-(4-trifluoromethylthiazol-2-yl)pyrimidine 
• 1251166-34-3 4-(4-methoxybenzyloxy)-6-(5-methylthiophen-2-yl)-2-(4-trifluoromethylthiazol-2-yl)pyrimidine 
• 1251166-87-6 6-phenoxy-2-(4-trifluoromethylthiazol-2-yl)pyrimidin-4-ol 
• 204319-69-7 (4-(trifluoromethyl)thiazol-2-yl)methanol 
• 1251166-37-6 4-(4-methoxybenzyloxy)-6-(5-trifluoromethylthiophen-2-yl)-2-(4-trifluoromethylthiazol-2-yl)pyrimidine 

Relevant articles and documents

SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE

The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.

Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, and pharmaceutical compositions and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

HETEROCYCLIC COMPOUND

Provided is a compound having a melanin-concentrating hormone receptor antagonistic action and is useful as an agent for the prophylaxis or treatment of obesity and the like. A compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.